| Octagam |
125062 |
007 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
10% 5G |
Single-Use Bottle |
2014/07/11
|
Octapharma Pharmazeutika Produktionsges.m.b.H. |
Rx |
Licensed |
|
N/A |
| Octagam |
125062 |
008 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
10% 2G |
Single-Use Bottle |
2014/07/11
|
Octapharma Pharmazeutika Produktionsges.m.b.H. |
Rx |
Licensed |
|
N/A |
| Octagam |
125062 |
009 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
10% 10G |
Single-Use Bottle |
2014/07/11
|
Octapharma Pharmazeutika Produktionsges.m.b.H. |
Rx |
Licensed |
|
N/A |
| Afrezza |
022472 |
001 |
351(a) |
insulin human |
Powder |
Inhalation |
4UNITS/INH |
Single-Dose Cartridge |
2014/06/27
|
Mannkind Corporation |
Rx |
Licensed |
N/A |
N/A |
| Afrezza |
022472 |
002 |
351(a) |
insulin human |
Powder |
Inhalation |
8UNITS/INH |
Single-Dose Cartridge |
2014/06/27
|
Mannkind Corporation |
Rx |
Licensed |
N/A |
N/A |
| Alphanate |
102475 |
005 |
351(a) |
Antihemophilic Factor/von Willebrand Factor Complex (Human) |
For Injection |
Intravenous |
2000IU |
Single-Dose Vial |
2014/06/26
|
Grifols Biologicals LLC |
Rx |
Licensed |
|
N/A |
| Eloctate |
125487 |
001 |
351(a) |
Antihemophilic Factor (Recombinant), Fc Fusion protein |
For Injection |
Intravenous |
1500IU |
Single-Dose Vial |
2014/06/06
|
Bioverativ Therapeutics, Inc. |
Rx |
Licensed |
|
N/A |
| Eloctate |
125487 |
002 |
351(a) |
Antihemophilic Factor (Recombinant), Fc Fusion protein |
For Injection |
Intravenous |
1000IU |
Single-Dose Vial |
2014/06/06
|
Bioverativ Therapeutics, Inc. |
Rx |
Licensed |
|
N/A |
| Eloctate |
125487 |
003 |
351(a) |
Antihemophilic Factor (Recombinant), Fc Fusion protein |
For Injection |
Intravenous |
2000IU |
Single-Dose Vial |
2014/06/06
|
Bioverativ Therapeutics, Inc. |
Rx |
Licensed |
|
N/A |
| Eloctate |
125487 |
004 |
351(a) |
Antihemophilic Factor (Recombinant), Fc Fusion protein |
For Injection |
Intravenous |
3000IU |
Single-Dose Vial |
2014/06/06
|
Bioverativ Therapeutics, Inc. |
Rx |
Licensed |
|
N/A |
| Eloctate |
125487 |
005 |
351(a) |
Antihemophilic Factor (Recombinant), Fc Fusion protein |
For Injection |
Intravenous |
750IU |
Single-Dose Vial |
2014/06/06
|
Bioverativ Therapeutics, Inc. |
Rx |
Licensed |
|
N/A |
| Eloctate |
125487 |
006 |
351(a) |
Antihemophilic Factor (Recombinant), Fc Fusion protein |
For Injection |
Intravenous |
500IU |
Single-Dose Vial |
2014/06/06
|
Bioverativ Therapeutics, Inc. |
Rx |
Licensed |
|
N/A |
| Eloctate |
125487 |
007 |
351(a) |
Antihemophilic Factor (Recombinant), Fc Fusion protein |
For Injection |
Intravenous |
250IU |
Single-Dose Vial |
2014/06/06
|
Bioverativ Therapeutics, Inc. |
Rx |
Licensed |
|
N/A |
| Evarrest |
125392 |
003 |
351(a) |
Fibrin Sealant Patch |
Patch |
Topical |
55.5MG FIBRINOGEN&241.9IU THROMBIN/IN^2; 2x4 IN |
Pouch |
2014/05/27
|
Ethicon, Inc. |
Rx |
Licensed |
|
N/A |
| Entyvio |
125476 |
001 |
351(a) |
vedolizumab |
For Injection |
Intravenous |
300MG |
Single-Dose Vial |
2014/05/20
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
N/A |
N/A |
| Sylvant |
125496 |
001 |
351(a) |
siltuximab |
For Injection |
Intravenous |
100MG |
Single-Dose Vial |
2014/04/23
|
Recordati Rare Diseases, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Sylvant |
125496 |
002 |
351(a) |
siltuximab |
For Injection |
Intravenous |
400MG |
Single-Dose Vial |
2014/04/23
|
Recordati Rare Diseases, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Cyramza |
125477 |
001 |
351(a) |
ramucirumab |
Injection |
Intravenous |
100MG/10ML (10MG/ML) |
Single-Dose Vial |
2014/04/21
|
Eli Lilly and Company |
Rx |
Licensed |
N/A |
N/A |
| Cyramza |
125477 |
002 |
351(a) |
ramucirumab |
Injection |
Intravenous |
500MG/50ML (10MG/ML) |
Single-Dose Vial |
2014/04/21
|
Eli Lilly and Company |
Rx |
Licensed |
N/A |
N/A |
| Ragwitek |
125478 |
001 |
351(a) |
Short Ragweed Pollen Allergen Extract |
Tablet |
Sublingual |
12 AMB A 1-UNITS/Tablet |
Blister Pack |
2014/04/17
|
ALK - Abello A/S |
Rx |
Licensed |
|
N/A |